Gene Therapy Trends and Future Prospects

June 2020

Gene Therapies have come of age with several recent product approvals, an increasing number of clinical trials underway and considerable M&A activity and venture capital investment.
       
The road ahead, however, is not without challenges. What role does pre-existing patient immunity to viral vectors play in creating effective gene therapies? Is there sufficient manufacturing capacity and how can we decrease the cost of goods?
 
Check out the answers to these questions and more in BDO Managing Director Neal Gordon’s recent bylined article in BioProcess International.